The present invention relates to a new process for the preparation of crystalmodifications for use in the preparation of esomeprazole sodium salt. Further,the present invention also relates to the use of the new crystal modificationsfor the treatment of gastrointestinal disorders, pharmaceutical compositionscontaining them as well as the crystal modifications, as such.